Loading
Latest filing published 14 Feb 2023 for CytoDyn Inc..
No signal scores available.
Arvin Cyrus Arman appears in our data through filings on CytoDyn Inc. shares, published by SEC (Form 4). Between 20 September 2022 and 13 February 2023, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 February 2023: a share grant, in CytoDyn Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations